Consun Pharmaceutical Group Ltd.
Important Dates
CONSUN PHARMACEUTICAL GROUP LTD.'s next confirmed earnings release is scheduled for March 24, 2027.
| Earnings Date | 3/24/2027 |
Share Statistics
As of December 31, 2025, CONSUN PHARMACEUTICAL GROUP LTD. has 839.96M shares outstanding.
| Shares Outstanding | 839.96M |
Financial Position
As of December 31, 2025, CONSUN PHARMACEUTICAL GROUP LTD. maintains a current ratio of 3.22, meaning it holds 3.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 3.22 |
| Quick Ratio | 2.73 |
| Debt / Equity | 4.40 |
Financial Efficiency
These figures cover the twelve months ended December 31, 2025.
| Employee Count | 3,139.50 |
Stock Price Statistics
As of the close on August 31, 2026, CONSUN PHARMACEUTICAL GROUP LTD.'s stock has gained approximately 58.93% over the past 52 weeks.
| 52-Week Price Change | 58.93% |
Balance Sheet
USDAs of December 31, 2025, CONSUN PHARMACEUTICAL GROUP LTD. holds 558.23M in cash and equivalents against 30.45M in total debt, resulting in a net debt position of -147.93M. Total book value stands at 648.55M, with working capital of 453.97M providing operational flexibility.
| Cash & Cash Equivalents | 558.23M |
| Total Debt | 30.45M |
| Net Debt | -147.93M |
| Equity (Book Value) | 648.55M |
| Book Value Per Share | 0.77 |
| Working Capital | 453.97M |